Care Max, Inc. CMAX
We take great care to ensure that the data presented and summarized in this overview for CareMax, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CMAX
View all-
Antipodean Advisors LLC New York, NY200KShares$578,0002.33% of portfolio
-
Jefferies Group LLC New York, NY65.5KShares$189,2420.0% of portfolio
-
Milestone Wealth, LLC Buffalo, NY5KShares$14,4500.02% of portfolio
-
Cwm, LLC1.14KShares$3,2800.0% of portfolio
-
Baystate Wealth Management LLC900Shares$2,6010.0% of portfolio
Latest Institutional Activity in CMAX
Top Purchases
Top Sells
About CMAX
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
Insider Transactions at CMAX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
Kevin Berg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,123
+50.0%
|
-
|
|
Nov 17
2023
|
James E Flynn Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
12,123
+50.0%
|
-
|
|
Nov 17
2023
|
Ryan O Quinn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,123
+50.0%
|
-
|
|
Nov 17
2023
|
Torre Ralph De La Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,927
+50.0%
|
-
|
|
Jun 08
2023
|
Kevin Wirges EVP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,433
+2.61%
|
-
|
|
Jun 08
2023
|
Alberto De Solo EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+18.53%
|
-
|
|
Jun 08
2023
|
Carlos A. De Solo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,300
+18.53%
|
-
|
|
May 12
2023
|
David Shulkin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,585
+23.93%
|
-
|
|
May 12
2023
|
Kevin Wirges EVP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,632
+6.19%
|
-
|
|
May 12
2023
|
Carlos A. De Solo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,293
+41.37%
|
-
|
|
May 12
2023
|
Jose Ramon Rodriguez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,381
+36.1%
|
-
|
|
May 12
2023
|
Bryan Cho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,187
+28.97%
|
-
|
|
May 12
2023
|
Alberto De Solo EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,108
+41.37%
|
-
|
|
May 12
2023
|
Vincent Omachonu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,187
+35.29%
|
-
|
|
May 12
2023
|
Beatriz Maria Assapimonwait Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,187
+33.81%
|
-
|
|
Mar 13
2023
|
Bryan Cho Director |
BUY
Open market or private purchase
|
Direct |
10,000
+29.85%
|
$30,000
$3.46 P/Share
|
|
Nov 11
2022
|
Beatriz Maria Assapimonwait Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,500
+50.0%
|
-
|
|
Nov 11
2022
|
Carlos A. De Solo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,300
+50.0%
|
-
|
|
Nov 11
2022
|
Bryan Cho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+50.0%
|
-
|
|
Nov 11
2022
|
David Shulkin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,500
+27.68%
|
-
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 223K shares |
|---|